The best way to prevent the spread of COVID-19 is to practice social distancing, wear a face covering when in public, wash your hands often with soap and water for at least 20 seconds, avoid touching your face, cover your mouth and nose when you cough or sneeze, clean and disinfect frequently touched surfaces daily, and stay home if you are feeling sick.
The report also found that the majority of Canadians who did not get vaccinated were between the ages of 12 and 24, with only 40 per cent of this age group receiving the vaccine. This is in contrast to those aged 25 and over, where more than two-thirds (68 per cent) reported being vaccinated. The report also noted that women were more likely to be vaccinated than men, with 63 per cent of women receiving the vaccine compared to 54 per cent of men.
The report concluded that while a majority of Canadians chose not to get vaccinated against H1N1 last year, there was still a significant uptake in vaccination rates compared to previous years. It noted that overall, about one-third (33 per cent) of Canadians aged 12 and over received the H1N1 vaccine during the 2009-2010 influenza season.
That’s a far cry from the 80 per cent of Canadians that health officials had hoped to vaccinate.
The low uptake has been blamed on a variety of factors, including vaccine hesitancy, lack of access to the vaccine and confusion over who was eligible for the shot.
It is a contagious respiratory illness caused by a virus that can be spread from person to person through coughing, sneezing, or contact with an infected person. Symptoms of H1N1 include fever, cough, sore throat, runny nose, body aches, headache, chills and fatigue. In some cases it can lead to more serious complications such as pneumonia or even death. The best way to prevent the spread of H1N1 is to practice good hygiene such as washing your hands often and avoiding close contact with people who are sick. Vaccines are also available for those at high risk of developing complications from the virus.
The vaccine was distributed to provinces and territories across Canada, with each province and territory responsible for its own distribution.
Public health agencies used a variety of tactics to encourage Canadians to get the vaccine. These included television and radio advertisements, posters, brochures, and social media campaigns. Additionally, many public health agencies held events such as flu clinics and vaccination drives in order to make it easier for people to access the vaccine.
Despite these efforts, most Canadians ended up feeling they did not need to get the vaccine. This could be due to a number of factors including lack of awareness about the severity of the virus or concerns about potential side effects from the vaccine. It is also possible that some people felt that their risk of contracting the virus was low enough that getting vaccinated was unnecessary.
Other reasons included not wanting to get the vaccine (9%), not having enough information (7%), and being worried about side effects (6%).
The agency also notes that the vaccine supply is expected to increase over time, and that it has secured additional doses from other suppliers.
The decision to maintain the original vaccine order was made in order to ensure that Canadians would receive the best possible protection from the virus. By providing two doses of the vaccine, it increases the chances of immunity and reduces the risk of infection. Additionally, it allows for a more comprehensive assessment of the effectiveness of the vaccine, which can help inform future decisions about how to best protect Canadians from H1N1 and other infectious diseases.
This is a positive sign that Canadians are taking the threat of H1N1 seriously and are doing their part to protect themselves and others from the virus. It also shows that Canadians have access to reliable information about the virus and its effects, which has enabled them to make informed decisions about their health.
Other groups, such as the elderly and those with underlying health conditions, were also prioritized for early access to the vaccine.
For example, in 2017, the vaccination rate for Indigenous children aged 2 to 7 was 86.3%, compared to 81.2% for non-Indigenous children of the same age group. Similarly, the vaccination rate for children living in rural areas was 82.7%, compared to 81.4% for those living in urban areas.
Overall, it appears that rates of vaccination are generally higher among certain groups, such as Indigenous and rural populations. This could be due to a variety of factors, including increased access to healthcare services in these areas or greater awareness of the importance of vaccinations among these populations.
This suggests that the majority of health-care workers chose to get vaccinated. This is likely due to their increased exposure to the virus and their knowledge of the importance of vaccinations in preventing its spread.
This suggests that pregnant women are not more likely to get the vaccine than those who are not pregnant.
“The data will provide a better understanding of the impact of the pandemic on Canadians, and help inform policy decisions,” said the agency.
Statistics Canada said it would continue to monitor the situation and release more detailed information as it becomes available.
The survey collected data on a variety of topics, including health status, lifestyle and risk factors, health care utilization, and socio-demographic characteristics. The survey was conducted by Statistics Canada in partnership with Health Canada.
The census also excludes people who are not Canadian citizens or permanent residents, such as temporary foreign workers and international students.
This means that 12,717 individuals were interviewed by telephone and 7,138 individuals were interviewed in person.
This means that 73.1% of the people who were asked to participate in the survey responded.
According to Statistics Canada, only about one-third of Canadians aged 6 months and older received the H1N1 vaccine during the 2009-2010 flu season. This was significantly lower than the uptake rate for seasonal flu vaccines, which ranged from 40 to 60 percent. The low uptake rate for the H1N1 vaccine was likely due to a combination of factors, including public skepticism about the safety and effectiveness of the vaccine, as well as logistical issues related to its availability.